The cases are the latest since Clade I mpox was first detected in the US, also in California last November in a resident of ...

Pricing issues have taken precedence as CVS Health’s (NYSE:CVS) pharmacy benefit manager, CVS Caremark, continues to hold off ...

Currently available medications could be enough to end the HIV epidemic in the United States, provided people can access and ...

Nigerian lawmakers on Wednesday launched an investigation into how $4.6 billion in international aid grants between 2021 and ...

A new analysis finds that generic lenacapavir, a twice-yearly HIV preventive treatment, could be mass produced for just $25 ...

The federal government shutdown has brought respiratory virus surveillance to a halt at the national level, leaving local governments, health systems and the general public with critical blind spots ...

The drug can be produced for as little as $25 per person annually, but even at $2000 per person, it can reduce new US infections almost entirely, a researcher says.

This article, Part One of the Mercury’s Pulse Check series, was produced as a project for the USC Annenberg Center for Health ...

“Violence, anti-gay or not, is a problem for police or social workers, not healthcare workers.” In fact, the American Medical ...

We finally have the technology, infrastructure, and the political will to end the US HIV epidemic, write the Brown University ...

The American South has the highest HIV rates in the country, accounting for more than half of new HIV diagnoses nationwide in ...

The interdisciplinary research team at the School of Medicine will work together to explore the effects of factors like ...